FFL
BIO icon

Financial Freedom LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Financial Freedom LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33
Closed -$9.2K – 135
2026
Q1 		$9.2K Buy
+33
New +$9.5K ﹤0.01% 309

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Financial Freedom LLC's BIO Position: Q2 2026 in Review

Financial Freedom LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 33 shares — an estimated $9.2K sold.

Financial Freedom LLC first reported a position in BIO in Q1 2026 and held it in 1 quarter. The position peaked at $9.2K in Q1 2026. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Financial Freedom LLC reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 33 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $9.2K.
  • Financial Freedom LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and held it in 1 quarter.
  • Financial Freedom LLC's Bio-Rad Laboratories Class A position peaked at $9.2K in Q1 2026.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.